Khartis Therapeutics
Develops oral small molecule therapies for immunological and chronic diseases
$50MSeries B
Role not disclosedLoading investors…
Activity from announced rounds
Develops oral small molecule therapies for immunological and chronic diseases
Develops interventional therapies for pulmonary hypertension and heart failure
Pitching Lilly Asia Ventures? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room